Innovation Pharmaceuticals Inc (IPIX)

[sunspotter]

"None of the SAEs were classified by the Investigator as related to Brilacidin."

That's the beauty of a placebo controlled study - you don't need to rely on the opinion of the investigators, you can look at the comparative data.

In the case of the OM study, you would have to be self-deluded to think the difference in both SAEs and non-Serious AEs between the two groups was purely down to chance.

Have a look for yourself - I thoroughly recommend relying on data rather than opinions, or interpretations from interested parties:


https://clinicaltrials.gov/ct2/show/results/NCT02324335?term=brilacidin&draw=1&rank=1